Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Azodicarbonamide is a synthetic chemical compound with the molecular formula C2H4N4O2. It appears as a yellow to orange-red odorless crystalline powder. Azodicarbonamide is primarily used industrially as a blowing agent in the manufacture of foamed plastics and rubber products. In food processing—specifically bread making—it has been used as a flour whitening agent and dough conditioner to improve machinability and texture; this use is approved in some countries but banned or restricted in others due to health concerns[1][3][7]. Mechanistically, it acts as an oxidizing agent when used in baking[7]. In vitro studies have shown that it can decrease intracellular deoxyribonucleotide pools and **inhibit ribonucleotide reductase**; it also **inhibits HIV-1 by targeting nucleocapsid CCHC domains**. Azodicarbonamide was introduced into Phase I/II clinical trials for advanced AIDS (HIV infection) in Europe but remains primarily an industrial chemical rather than a pharmaceutical drug[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on azodicarbonamide.